A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.
This study has been completed.
Study NCT00269880
Information provided by Centocor, Inc.
First Received on December 22, 2005.
Last Updated on April 23, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional drug interventions recognized in this trial
